Accretion Pharmaceuticals Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 352,800 (12%) | — | ₹356 Cr |
| NII (HNI) | — | 1,222,800 (42%) | — | ₹1,235 Cr |
| Retail | — | 1,222,800 (42% | — | ₹1,235 Cr |
| Market Maker | — | 147,600 (5%) | — | ₹15 Cr |
| Σ Total | — | 2,946,000 (100%) | — | ₹29,755 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹121,200 |
| Retail (Max) | 13 | 15,600 | ₹1,575,600 |
| S-HNI (Min) | 14 | 16,800 | ₹1,696,800 |
| B-HNI (Min) | 67 | 80,400 | ₹8,120,400 |
Financial Statements Amount in ₹ Crore
| Metric | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 36 | 34 | 30 |
| Profit After Tax | 5 | 4 | 0 |
| Net Worth | 14 | 5 | 4 |
| Total Assets | 40 | 27 | 21 |
| Reserves & Surplus | 5 | 1 | 0 |
| Total Borrowing | 14 | 13 | 8 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Capital expenditure towards purchase of new equipment/ machineries, etc. – 2.70
- Capital expenditure towards upgradation of existing manufacturing facility – 4.66
- Repayment/prepayme nt of certain borrowings availed by the Company – 0.99
- Funding working capital requirements – 14.68
- General Corporate Purpose – 4.43
Company Overview
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.
The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).
The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems.
The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat.
The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East.
Product Portfolio and Services
- Tablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines.
- Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments.
- External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments.
- Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and general health.
As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.
Competitive Strength:
- Experienced Promoters and Management Team.
- Long-standing relationship with clients and suppliers.
- Focus on providing quality products.
- Management has built a supply chain and customer relations, creating goodwill and trust.